GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Beijing Strong Biotechnologies Inc (SZSE:300406) » Definitions » EV-to-EBITDA

Beijing Strong Biotechnologies (SZSE:300406) EV-to-EBITDA : 16.96 (As of May. 08, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Beijing Strong Biotechnologies EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Beijing Strong Biotechnologies's enterprise value is ¥11,086 Mil. Beijing Strong Biotechnologies's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥654 Mil. Therefore, Beijing Strong Biotechnologies's EV-to-EBITDA for today is 16.96.

The historical rank and industry rank for Beijing Strong Biotechnologies's EV-to-EBITDA or its related term are showing as below:

SZSE:300406' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.56   Med: 22.96   Max: 101.73
Current: 16.96

During the past 13 years, the highest EV-to-EBITDA of Beijing Strong Biotechnologies was 101.73. The lowest was 3.56. And the median was 22.96.

SZSE:300406's EV-to-EBITDA is ranked worse than
53.45% of 116 companies
in the Medical Diagnostics & Research industry
Industry Median: 16.255 vs SZSE:300406: 16.96

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-08), Beijing Strong Biotechnologies's stock price is ¥18.56. Beijing Strong Biotechnologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.900. Therefore, Beijing Strong Biotechnologies's PE Ratio for today is 20.62.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Beijing Strong Biotechnologies EV-to-EBITDA Historical Data

The historical data trend for Beijing Strong Biotechnologies's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Strong Biotechnologies EV-to-EBITDA Chart

Beijing Strong Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.87 83.76 20.68 18.68 16.72

Beijing Strong Biotechnologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.66 25.28 20.70 16.72 17.57

Competitive Comparison of Beijing Strong Biotechnologies's EV-to-EBITDA

For the Diagnostics & Research subindustry, Beijing Strong Biotechnologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Strong Biotechnologies's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Beijing Strong Biotechnologies's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Beijing Strong Biotechnologies's EV-to-EBITDA falls into.



Beijing Strong Biotechnologies EV-to-EBITDA Calculation

Beijing Strong Biotechnologies's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=11085.936/653.817
=16.96

Beijing Strong Biotechnologies's current Enterprise Value is ¥11,086 Mil.
Beijing Strong Biotechnologies's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥654 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Strong Biotechnologies  (SZSE:300406) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Beijing Strong Biotechnologies's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=18.56/0.900
=20.62

Beijing Strong Biotechnologies's share price for today is ¥18.56.
Beijing Strong Biotechnologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.900.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Beijing Strong Biotechnologies EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Strong Biotechnologies (SZSE:300406) Business Description

Traded in Other Exchanges
N/A
Address
No. 15 Hua Yuan Dong Lu, 5th Floor, Kuang Yi Building, Haidian District, Beijing, CHN, 100191
Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.

Beijing Strong Biotechnologies (SZSE:300406) Headlines

No Headlines